SPOTLIGHT: Sanofi files new vaccine tech


Sanofi Pasteur has submitted the first vaccine delivered by an intradermal microinjection system for European approval. The vaccine is delivered to the dermal layer, triggering a response in specialized immune cells. Report

Suggested Articles

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.

Takeda has spent considerable resources on its phase 3 dengue vaccine, and now data show the shot was 80% effective in preventing dengue.